Genpact (NYSE:G - Get Free Report) is expected to issue its Q1 2026 results after the market closes on Thursday, May 7th. Analysts expect the company to announce earnings of $0.93 per share and revenue of $1.2893 billion for the quarter. Investors may visit the the company's upcoming Q1 2026 earning results page for the latest details on the call scheduled for Thursday, May 7, 2026 at 5:00 PM ET.
Genpact (NYSE:G - Get Free Report) last issued its earnings results on Friday, February 6th. The business services provider reported $0.97 earnings per share for the quarter, beating analysts' consensus estimates of $0.93 by $0.04. Genpact had a return on equity of 22.02% and a net margin of 10.88%.The firm had revenue of $1.32 billion for the quarter, compared to analysts' expectations of $1.31 billion. During the same quarter last year, the firm earned $0.91 earnings per share. The firm's revenue for the quarter was up 5.6% compared to the same quarter last year. On average, analysts expect Genpact to post $4 EPS for the current fiscal year and $4 EPS for the next fiscal year.
Genpact Price Performance
Shares of Genpact stock opened at $33.85 on Thursday. Genpact has a twelve month low of $33.53 and a twelve month high of $50.41. The stock has a market capitalization of $5.75 billion, a P/E ratio of 10.81, a PEG ratio of 1.00 and a beta of 0.74. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.46. The business's fifty day moving average price is $37.60 and its 200 day moving average price is $41.48.
Genpact Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Wednesday, June 10th will be issued a $0.1875 dividend. The ex-dividend date is Wednesday, June 10th. This represents a $0.75 dividend on an annualized basis and a yield of 2.2%. Genpact's dividend payout ratio (DPR) is presently 23.96%.
Wall Street Analyst Weigh In
A number of research analysts recently weighed in on G shares. Mizuho reduced their target price on Genpact from $51.00 to $49.00 and set a "neutral" rating on the stock in a report on Tuesday, February 10th. Susquehanna set a $42.00 target price on Genpact in a report on Friday, February 6th. Needham & Company LLC reduced their target price on Genpact from $53.00 to $50.00 and set a "buy" rating on the stock in a report on Friday, February 6th. Citigroup upgraded Genpact from a "hold" rating to a "strong-buy" rating in a report on Friday, February 13th. Finally, Wall Street Zen cut Genpact from a "buy" rating to a "hold" rating in a report on Saturday, March 14th. One research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat, Genpact has a consensus rating of "Hold" and a consensus target price of $47.29.
Get Our Latest Research Report on G
Insider Activity at Genpact
In other Genpact news, CEO Balkrishan Kalra sold 2,800 shares of the business's stock in a transaction dated Wednesday, March 4th. The stock was sold at an average price of $40.77, for a total transaction of $114,156.00. Following the transaction, the chief executive officer owned 525,007 shares in the company, valued at $21,404,535.39. The trade was a 0.53% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.58% of the stock is currently owned by corporate insiders.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently modified their holdings of the stock. Johnson Financial Group Inc. acquired a new position in shares of Genpact during the third quarter worth about $29,000. iSAM Funds UK Ltd acquired a new position in shares of Genpact during the third quarter worth about $29,000. Los Angeles Capital Management LLC acquired a new position in shares of Genpact during the fourth quarter worth about $33,000. CIBC Private Wealth Group LLC lifted its stake in shares of Genpact by 79.9% during the fourth quarter. CIBC Private Wealth Group LLC now owns 750 shares of the business services provider's stock worth $35,000 after purchasing an additional 333 shares in the last quarter. Finally, Northwestern Mutual Wealth Management Co. grew its stake in shares of Genpact by 47.5% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 823 shares of the business services provider's stock valued at $39,000 after acquiring an additional 265 shares in the last quarter. Institutional investors and hedge funds own 96.03% of the company's stock.
Genpact Company Profile
(
Get Free Report)
Genpact is a global professional services firm specializing in digitally powered business process management and services. The company partners with clients across industries to design, transform and run key operations, leveraging data analytics, artificial intelligence, automation and domain expertise. Its offerings span finance and accounting, supply chain management, procurement, customer experience, risk and compliance, and other critical business functions.
Founded in 1997 as the business process outsourcing arm of General Electric and originally known as GE Capital International Services, the company rebranded as Genpact in 2005 and completed its initial public offering on the New York Stock Exchange in 2007 under the ticker symbol “G.” Over time, Genpact has expanded beyond traditional outsourcing to focus on digital transformation and innovation, helping organizations accelerate growth and improve operational efficiency.
Headquartered in New York City, Genpact serves clients in more than 30 countries across North America, Latin America, Europe and Asia Pacific.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.